Retraction: miR-5089-5p suppresses castration-resistant prostate cancer resistance to enzalutamide and metastasis via miR-5089-5p/SPINK1/ MAPK/MMP9 signaling
Aging (Albany NY)
.
2020 Oct 31;12(20):20930.
doi: 10.18632/aging.104212.
Epub 2020 Oct 31.
Authors
Zhi-Chao Wang
1
,
Yan Li
2
,
Ke-Liang Wang
1
,
Lu Wang
1
,
Bo-Sen You
1
,
Dan-Feng Zhao
1
,
Zhong-Qing Liu
1
,
Rui-Zhe Fang
1
,
Jia-Qi Wang
1
,
Wei Zhang
1
,
Jin-Ming Zhang
1
,
Wan-Hai Xu
1
Affiliations
1
Heilongjiang Key Laboratory of Scientific Research in Urology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, 150001, China.
2
Department of Anesthesia, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, 150001, China.
PMID:
33156816
PMCID:
PMC7655173
DOI:
10.18632/aging.104212
No abstract available
Publication types
Retraction Notice